BWV insider filings
Blue Water Biotech, Inc. — 24 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-06-01. Screen BWV transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for BWV between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Blue Water Biotech, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-06-01 | 4 | Jeremic Vuk — Director | Grant/award (A): 6,360 @ $0 | EDGAR |
| 2023-06-01 | 4 | Ramdeen Timothy R. — Director | Grant/award (A): 6,360 @ $0 | EDGAR |
| 2023-06-01 | 4 | Tarsh Simon — Director | Grant/award (A): 6,360 @ $0 | EDGAR |
| 2023-06-01 | 4 | SAPIRSTEIN JAMES — Director | Grant/award (A): 6,360 @ $0 | EDGAR |
| 2023-05-11 | 4 | Henderson Erin — Chief Business Officer | Grant/award (A): 150,000 | EDGAR |
| 2023-05-11 | 4 | Hernandez Joseph — CEO, Director, 10% owner | Grant/award (A): 150,000 | EDGAR |
| 2023-05-11 | 4 | Garfield Jon — Chief Financial Officer | Grant/award (A): 100,000 | EDGAR |
| 2023-04-12 | 4 | Cincinnati Cornerstone Investors BWV I, LLC — 10% owner Cincinnati Cornerstone Capital LLC | Other (J): 1,200,000 @ $0 | EDGAR |
| 2023-01-30 | 4 | Ramdeen Timothy R. — Director | Grant/award (A): 2,386 (derivative) @ $0 | EDGAR |
| 2022-11-21 | 4 | Cincinnati Cornerstone Investors BWV I, LLC — 10% owner Cincinnati Cornerstone Capital LLC | Other (J): 750,000 @ $0 | EDGAR |
| 2022-11-09 | 4 | Jeremic Vuk — Director | Grant/award (A): 3,610 (derivative) @ $0 | EDGAR |
| 2022-08-29 | 4 | Cincinnati Cornerstone Investors BWV I, LLC — 10% owner Cincinnati Cornerstone Capital LLC | Other (J): 500,000 @ $0 | EDGAR |
| 2022-08-24 | 4 | Tarsh Simon — Director | Grant/award (A): 4,073 (derivative) @ $0 | EDGAR |
| 2022-08-23 | 4 | Shaw Allan — Director | Tax withholding (F): 29,636 @ $0.01 · Sale (S): 29,636 @ $3.94 · Tax withholding (F): 29,636 (derivative) @ $0.01 | EDGAR |
| 2022-08-22 | 4 | Henderson Erin — Chief Business Officer | Tax withholding (F): 24,752 @ $0.01 · Tax withholding (F): 4,834 @ $0.01 · Sale (S): 4,834 @ $3.97 · Tax withholding (F): 24,810 (derivative) @ $0.01 · Tax withholding (F): 4,834 (derivative) @ $0.01 | EDGAR |
| 2022-08-22 | 4 | Hernandez Joseph — CEO, Director, 10% owner | Sale (S): 442,539 @ $4.96 · Sale (S): 76,841 @ $4.21 · Sale (S): 30,269 @ $4.10 | EDGAR |
| 2022-05-27 | 4 | Venerable Michael — Director | Grant/award (A): 4,655 (derivative) @ $0 | EDGAR |
| 2022-05-27 | 4 | Murphy Kimberly M — Director | Grant/award (A): 4,655 (derivative) @ $0 | EDGAR |
| 2022-05-27 | 4 | Henderson Erin — Chief Business Officer | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2022-05-27 | 4 | Shaw Allan — Director | Grant/award (A): 4,655 (derivative) @ $0 | EDGAR |
| 2022-05-27 | 4 | Hernandez Joseph — CEO, Director, 10% owner | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2022-05-27 | 4 | SAPIRSTEIN JAMES — Director | Grant/award (A): 50,575 (derivative) @ $0 | EDGAR |
| 2022-05-27 | 4 | Garfield Jon — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-02-24 | 4 | Cincinnati Cornerstone Investors BWV I, LLC — 10% owner Cincinnati Cornerstone Capital LLC — 10% owner | Conversion (C): 3,611,201 @ $0 · Conversion (C): 735,632 (derivative) @ $6.09 | EDGAR |
Recent 8-K events — Blue Water Biotech, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-09 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-26 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-23 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-19 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-04 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
Registration filings — Blue Water Biotech, Inc.
Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.
- SEC file 333-298259 (S-1) — latest: Amendment (S-1/A), filed 2026-08-31
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BWV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs